Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ARIPIPRAZOLE Cause End stage renal disease? 16 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 16 reports of End stage renal disease have been filed in association with ARIPIPRAZOLE (Aripiprazole). This represents 0.0% of all adverse event reports for ARIPIPRAZOLE.

16
Reports of End stage renal disease with ARIPIPRAZOLE
0.0%
of all ARIPIPRAZOLE reports
7
Deaths
8
Hospitalizations

How Dangerous Is End stage renal disease From ARIPIPRAZOLE?

Of the 16 reports, 7 (43.8%) resulted in death, 8 (50.0%) required hospitalization.

Is End stage renal disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ARIPIPRAZOLE. However, 16 reports have been filed with the FAERS database.

What Other Side Effects Does ARIPIPRAZOLE Cause?

Drug ineffective (5,566) Off label use (5,473) Product use in unapproved indication (4,792) Weight increased (4,636) Anxiety (3,076) Suicide attempt (2,796) Suicidal ideation (2,618) Condition aggravated (2,157) Insomnia (2,147) Akathisia (2,107)

What Other Drugs Cause End stage renal disease?

OMEPRAZOLE (10,356) ESOMEPRAZOLE (10,231) LANSOPRAZOLE (9,734) PANTOPRAZOLE (8,523) DEXLANSOPRAZOLE (4,800) RABEPRAZOLE (1,295) EMTRICITABINE\TENOFOVIR DISOPROXIL (721) TENOFOVIR DISOPROXIL (558) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (462) TACROLIMUS (361)

Which ARIPIPRAZOLE Alternatives Have Lower End stage renal disease Risk?

ARIPIPRAZOLE vs ARIPIPRAZOLE LAUROXIL ARIPIPRAZOLE vs ARIXTRA ARIPIPRAZOLE vs ARMODAFINIL ARIPIPRAZOLE vs AROMASIN ARIPIPRAZOLE vs ARSENIC TRIOXIDE

Related Pages

ARIPIPRAZOLE Full Profile All End stage renal disease Reports All Drugs Causing End stage renal disease ARIPIPRAZOLE Demographics